Elosulfase Alfa

ATC A16AB12 · 6 markets · 8 records

Elosulfase Alfa 6 markets · 8 records Forms

GB 2 records · 1 strengths

  • 5 mg/5 mLinjectionVimizim 5mg/5ml concentrate for solution for infusion vialsVimizim 5mg/5ml solution for infusion vials also in US

AU 2 records · 2 strengths

  • 1 mg/mLinjectionVIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial unknown

Records without a stated strength · 1 VIMIZIM

US 1 records · 1 strengths

CA 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 VIMIZIM CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 VIMIZIM

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.